Incidence and prognostic significance of acute renal failure in myeloablative and non-myeloablative allogeneic stem cell transplant. single center experience

被引：0

作者：

Sitges, Marta ^{[1
]}

Ferra, Christelle ^{[1
]}

Soler, Jordi ^{[2
]}

Morgades, Mireia ^{[1
]}

Jose Jimenez, Maria ^{[1
]}

Hernandez, Ines ^{[1
]}

Torrent, Anna ^{[1
]}

Pena, Marta ^{[1
]}

Gener, Georgina ^{[1
]}

Franch, Mireia ^{[1
]}

Santos, Mireia ^{[1
]}

Canamero, Eloi ^{[1
]}

Comes, Martina ^{[1
]}

Espasa, Andrea ^{[1
]}

Batlle, Montserrat ^{[1
]}

Moreno, Miriam ^{[1
]}

Vives, Susana ^{[1
]}

Manuel Sancho, Juan ^{[1
]}

Xicoy, Blanca ^{[1
]}

Oriol, Albert ^{[1
]}

Abril, Laura ^{[1
]}

Ibarra, Gladys ^{[1
]}

Maria Ribera, Jose ^{[1
]}

机构：

[1] Univ Autonoma Barcelona, Inst Catala Oncol, Josep Carreras Res Inst, Hosp Germans Trias & Pujol, Badalona, Spain

[2] Hosp Badalona Germans Trias & Pujol, Badalona, Spain

来源：

BONE MARROW TRANSPLANTATION | 2019年 / 54卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P197

引用

页码：274 / 274

页数：1

共 50 条

[31] Non-myeloablative allogeneic stem cell transplant in an idiopathic thrombocytopenic purpura patient: a case report
Pala, C. P.
Buyukoglan, R.
Altuner, Y.
Kurnaz, F.
Kaynar, L.
Sivgin, S.
Keklik, M.
Eser, B.
Cetin, M.
BONE MARROW TRANSPLANTATION, 2013, 48 : S541 - S541
[32] Post-transplant lymphoproliferative disorder following non-myeloablative allogeneic stem cell transplantation
Snyder, MJ
Stenzel, TT
Lagoo, AS
Rizzieri, DA
Chao, N
Buckley, PJ
Gong, JZ
LABORATORY INVESTIGATION, 2003, 83 (01) : 253A - 253A
[33] Post-transplant lymphoproliferative disorder following non-myeloablative allogeneic stem cell transplantation
Snyder, MJ
Stenzel, TT
Lagoo, AS
Rizzieri, DA
Chao, N
Buckley, PJ
Gong, JZ
MODERN PATHOLOGY, 2003, 16 (01) : 253A - 253A
[34] Single institution experience with a non-myeloablative allogeneic stem cell transplant conditioning regimen using fludarabine and total body irradiation (TBI).
Lin, TS
Elder, PJ
Penza, SL
Avalos, BR
Farag, SS
Copelan, EA
BLOOD, 2003, 102 (11) : 730A - 731A
[35] A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
Atilla, Erden
Atilla, Pinar Ataca
Demirer, Taner
BALKAN MEDICAL JOURNAL, 2017, 34 (01) : 1 - 9
[36] NON-MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION (NST) IN PATIENTS WITH HIGH RISK LYMPHOMA: A SINGLE CENTRE EXPERIENCE
Console, Giuseppe
Messina, Giuseppe
Martino, Massimo
Morabito, Fortunato
Irrera, Giuseppe
Pucci, Giulia
Penna, Giuseppa
Cuzzola, Maria
Iacopino, Olga
Stelitano, Caterina
Callea, Vincenzo
Mamone, Domenico
Kropp, Maria Grazia
Molica, Stefano
Abbadessa, Antonio
Iacopino, Pasquale
ANNALS OF ONCOLOGY, 2004, 15 : 79 - 79
[37] Allogeneic non-myeloablative stem cell transplantation for refractory rheumatoid arthritis
Burt, R
Oyama, Y
Barr, W
Traynor, A
BONE MARROW TRANSPLANTATION, 2003, 31 : S145 - S146
[38] Incidence and outcome of thrombotic microangiopathy after allogeneic peripheral blood stem cell transplantation with non-myeloablative conditioning compared with myeloablative conditioning
Willems, E
Baron, F
Fillet, G
Beguin, Y
BONE MARROW TRANSPLANTATION, 2006, 37 : S46 - S46
[39] Non-myeloablative stem cell transplant: A dose-finding study
Bron, D
Zachee, P
Maertens, J
Doyen, C
Van den Berghe, P
Ferrant, A
Noens, L
Schroyens, W
Selleslag, D
Demuynck, H
Triffet, A
De Meuter, A
Boogaerts, M
BLOOD, 2002, 100 (11) : 398B - 398B
[40] Non-myeloablative allogeneic hematopoietic stem cell transplantation in patients with acute myelogenous leukemia.
Shapira, Michael Y.
Panagiotis, Tsirigotis D.
Or, Reuven
Resnick, Igor B.
Gesundheit, Benjamin
Slavin, Shimon
BLOOD, 2006, 108 (11) : 863A - 863A

← 1 2 3 4 5 →